Novonix (ASX:NVX) Big Customers, Slipping Timelines, and a Market Losing Patience
The Cost of Optimistic Timelines in Battery Manufacturing
Novonix has experienced a volatile year, with the share price ranging from highs near A$1.00 to more recent levels around A$0.42. That decline reflects a series of setbacks that have weighed on investor confidence in Novonix and reshaped the near term growth narrative.
Around November, the company lost a major supply agreement with Stellantis that was expected to cover approximately 86,000 tonnes of battery material. This was a meaningful blow, as the agreement had been central to expectations around future scale and revenue visibility.
More recently, the Novonix stock fell a further 17% following an announcement that the timeline for an offtake agreement linked to Panasonic had been delayed. Importantly, this appears to be a timing issue rather than a fundamental breakdown in the project. In October 2025, the company confirmed that installation and commissioning of the mass production equipment required to meet Panasonic’s qualification standards had been completed. The key issue now is that revenue is likely to arrive later than originally expected, rather than there being a structural problem with the build out itself.
Looking beyond the short term, the broader backdrop remains supportive. The push for US onshoring of critical mineral manufacturing continues to create long term tailwinds across energy storage, battery materials, and electrification markets.
That said, Novonix now needs to demonstrate consistent execution. Proving the ability to manufacture battery anode material at scale remains the critical challenge. As is often the case in this type of capital intensive, technically complex business, timelines can be optimistic.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips
Supportive Macro, Unforgiving Timelines
The foundation of a long-term growth story lies in powerful macro tailwinds reshaping the global graphite market. China currently accounts for roughly 95% of global graphite supply, and recurring export restrictions have amplified concerns about supply chain security. The US response, introducing tariffs on Chinese graphite, has already pushed domestic prices up to around US$14 per kilogram, effectively creating a pricing umbrella that benefits emerging non-Chinese producers.
The company is positioning itself to capitalise on growing demand for high-performance synthetic graphite, which remains the preferred choice for reliability and energy density in advanced battery applications. However, it is worth noting that Novonix’s production facilities still require time before reaching large-scale commercial output. In its latest presentation, management reiterated its ambition to expand production capacity tenfold by 2035, underscoring its confidence in the long-term potential of its US-based anode materials business.
The investor’s takeaway for Novonix
For investors, this highlights an important reality of businesses operating at the intersection of advanced manufacturing and critical minerals. Timelines and partnership milestones can, and often do, move.
We have seen this clearly over the past week with the Panasonic partnership, where the expected production timeline has shifted from 2026 to 2027 to meet the volume and quality requirements set out in the offtake agreement. This does not invalidate the opportunity, but it does reinforce that execution in this sector is rarely linear.
The key takeaway is that progress should be assessed over time, not quarter to quarter. Delays are part of the process, particularly when scaling complex production systems. What ultimately matters is whether the company can deliver against revised timelines and translate partnerships into sustainable commercial output.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Why ASX Healthcare Stocks Are Crashing- and Which One Looks Like a Buy
ASX healthcare stocks are crashing- which one is worth buying now? Three of Australia’s most premium ASX healthcare stocks have…
Webjet Group (ASX:WJL) Falls 25% on Failed Takeover and Downgraded Guidance- Value Trap or Hidden Opportunity?
Webjet Group Plunges After Takeover Collapse Webjet Group (ASX: WJL) plunged 25 per cent to A$0.58 on Friday, marking its…
Northern Star (ASX:NST) Delivered a 49% Profit Surge- Is It Still a Buy at These Levels?
Northern Star profit surges on gold – buy now or wait? Northern Star Resources (ASX: NST) just posted its best…